Cargando…
Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance
Rapamycin extends lifespan in mice, but can have a number of undesirable effects that may ultimately limit its utility in humans. The canonical target of rapamycin, and the one thought to account for its effects on lifespan, is the mammalian/mechanistic target of rapamycin, complex 1 (mTORC1). We ha...
Autores principales: | Ye, Lan, Widlund, Anne L., Sims, Carrie A., Lamming, Dudley W., Guan, Yuxia, Davis, James G., Sabatini, David M., Harrison, David E., Vang, Ole, Baur, Joseph A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765582/ https://www.ncbi.nlm.nih.gov/pubmed/23929887 |
Ejemplares similares
-
Correction for: Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance
por: Ye, Lan, et al.
Publicado: (2020) -
Pharmacologic Means of Extending Lifespan
por: Lamming, Dudley W., et al.
Publicado: (2012) -
Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2
por: Ye, Lan, et al.
Publicado: (2012) -
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
por: Harrison, David E., et al.
Publicado: (2009) -
The Possible Cellular Mechanism for Extending Lifespan of Mice with Rapamycin
por: Li, Shulin
Publicado: (2009)